Follow-up Reports. Two business days after particular securities are fair-valued in accordance with these procedures, PNC will provide to VP Distributors by 12:00 p.m. (Eastern Time) an Excel file containing the following information, to the extent available: Cusip/Sedol Portfolio ID Security Long Name Country Closing Price Fair Value Price Opening Price in Local Market FV Price/Closing Price (expressed as percentage) Opening Price/FV Price (expressed as a percentage) Opening Price/Closing Price (expressed as a percentage)
Follow-up Reports. By no later than January 31st of the year immediately following the year on which the ten (10) year anniversary of the Completion Date falls, Grantee shall provide DEO with a written certification of the actual number of New Jobs created by each business as a result of the Project (including the name of each business), Retained Jobs retained by each business as a result of the Project (including the name of each business) (if applicable), and the amount of private capital investment made and paid for by private businesses at the location of the Project or in connection with the Project after the Effective Date (including the name of each business). This paragraph will survive termination of this Agreement.
Follow-up Reports. Aptalis shall be responsible for obtaining further information on AE reports occurring in the Territory and Strakan shall be responsible for obtaining further information on AE reports occurring outside the Territory. Specifically, the Parties’ respective responsibilities shall be for critical data elements that ensure a comprehensive AE description and a true clinical understanding of the case or to ensure sufficient data to secure a “valid” case (a patient with at least one patient identifier, a reporter, an event, where the product is identified as the Product or glyceryl trinitrate unknown). Additional information may include laboratory data, biopsy results, hospital discharge summaries, etc. Each Party will transmit follow-up information received within the timeframe and by the methods described above for serious and non-serious cases.
Follow-up Reports. Follow-up reports concerning the performance of any employee who has received an “Unacceptable” or “Needs Improvement” rating shall be prepared at three- month intervals. If, in the opinion of the appointing authority, the employee improves to the extent that the restoration of any merit step advancement previously withheld under provisions of Section 8.1 is justified, the appointing authority shall so recommend to the City Manager. Upon approval of the City Manager, such restoration shall be made and shall be effective on beginning date of a subsequent pay period as specified in the recommendation of the appointing authority.
Follow-up Reports. Forwarding of an AE report should not be delayed while further information is awaited. If all the necessary details are not available at the time that the initial report is forwarded, the Nominated Contact will make further contact by telephone, correspondence or personal visit to the reporter to obtain the missing information. When serious reports originate from pharmacists, nurses or consumers, efforts should be made to obtain further information about the case from the physician responsible for the patient. Any additional information, including final outcome, will be forwarded to Skye as an addendum or ‘follow-up’ to the original report. This follow-up information should be identified with Skye’s reference number. Submission of reports to Regulatory Authorities Reports originating in the Territory Skye is responsible for submitting AE reports to the EMEA and in other countries where it holds the Regulatory Approval. Mundipharma shall be responsible for submitting AE reports in countries where it holds the Regulatory Approval. A copy of all correspondence with the Regulatory Authority will be submitted to the other party. Reports originating in territories other than the Territory Skye will notify Mundipharma of any serious unexpected foreign reports for information. Where Mundipharma is holder of the Regulatory Approval Mundipharma will submit the report to the local Regulatory Authority if appropriate. Where Skye is the holder of the Regulatory Approval, notification will be by copy of the report submitted to the Regulatory Authority. The activities of both parties summarised below.
Follow-up Reports. Any observation/evaluation report which notes an area in need of correction shall 40 be handled in the following manner: within five (5) days of the signing of the observation report, the 41 Administration shall identify specific ways/means/steps that the teacher may use to correct the noted 42 problem. The method by which the correction process will be monitored and a realistic time frame for 43 doing so will also be noted. Two (2) copies of the above will be given to the teacher with one (1) to be 44 signed by the teacher within five (5) days and returned to the Administration, the other to be retained by 45 the teacher. The teacher’s signature does not necessarily indicate agreement with the report but only 46 acknowledges receipt of the report.
Follow-up Reports. 9.1. Subject to what is stated in paragraph 9.2 below, the Firm will, following the provision of the Initial Assessment Report, furnish written reports to the Fund on a regular basis, or as and when requested.
Follow-up Reports. Additional information should be sought on initial and/or follow-up SAE reports and Pregnancy Exposure Reports with incomplete information. The information obtained from the report source should be sufficient to provide a true and comprehensive description and medical confirmation of the SAE or pregnancy as it is understood at the time of follow-up. If available, follow-up information should include a summary of the relevant critical data found in medical records (e.g., discharge summaries, lot numbers, relevant laboratory and scan data, and autopsy reports as applicable). Institution shall be responsible for obtaining follow-up information for the SAEs occurring in this Study (including attempts to obtain medical confirmation), and shall demonstrate diligence in attempting to obtain such information by, among other things, maintaining written records of such attempts. Institution shall forward all follow-up information to Amgen within the same timeframes that it is required to provide initial reports, pursuant to Section 4 of this Schedule. The notification of subsequent follow-up information on the same case should reflect the same Sponsor’s unique case number.
Follow-up Reports. Additional information should be sought on initial and/or follow-up SAE reports and Pregnancy and Lactation Exposure Reports with incomplete information. The information obtained from the report source should be sufficient to provide a true and comprehensive description and medical confirmation of the SAE or pregnancy or lactation exposure as it is understood at the time of follow-up. If available, follow-up information should include a summary of the relevant critical data found in medical records (e.g., discharge summaries, lot numbers, relevant laboratory and scan data, and autopsy reports as applicable). Sponsor shall be responsible for obtaining follow-up information for the SAEs occurring in this Study (including attempts to obtain medical confirmation), and shall demonstrate diligence in attempting to obtain such information by, among other things, maintaining written records of such attempts. Sponsor shall forward all follow-up information to Company within the same timeframes that it is required to provide initial reports, pursuant to the section regarding AE Data Provisions. The notification of subsequent follow-up information on the same case should reflect the same Sponsor’s unique case number.
Follow-up Reports. DUSA shall request specific follow-up information as it may need to fulfill its regulatory obligations. XXXXXXX shall be responsible for acting on this request and for obtaining follow-up information on all ICSRs and pregnancy reports for Levulan(R) Kerastick(R) in the Territory according to its internal practices and procedures. XXXXXXX shall be responsible for collecting good quality data from the reporter in the Territory.
